Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

Both baricitinib and tofacitinib effectively reduce alopecia areata severity, with tofacitinib showing more improvement over longer use.

TAK-279 effectively reduces psoriasis symptoms and is safe.

Tofacitinib nanoparticles can safely and effectively treat alopecia areata by targeting hair follicles.

Deleting the Trf1 protein in mice is safe and may help prevent cancer without major side effects.

Tofacitinib helped regrow hair in patients with alopecia, with few side effects.

Topical tofacitinib shows promise as a future treatment for alopecia areata.

Tofacitinib can be effective in treating hair loss caused by alopecia areata.

Tofacitinib effectively treated severe hair loss in a patient who didn't respond to other treatments.

Tofacitinib significantly improved symptoms in a patient with overlapping autoimmune disorders.

Combining TCA with 5-FU is more effective and safer for treating keloids than TCA alone.

Tofacitinib temporarily regrew hair in a man with alopecia, but its effects didn't last.

Low levels of tenuazonic acid can severely damage vital organs.

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

Weekly 5 mg folate is enough to prevent methotrexate toxicity in rheumatoid arthritis patients.

A JAK inhibitor improved both severe hair loss and chronic skin disease in one patient.

A Brazilian teenager with severe hair loss had total hair regrowth with no side effects after using tofacitinib.

Tofacitinib may help regrow hair in alopecia areata patients.

Tofacitinib and baricitinib are similarly effective and safe for alopecia areata, but baricitinib works faster.

Tofacitinib partially improved hair regrowth in a patient with severe hair loss.

Tofacitinib may be effective for treating hair loss caused by alopecia areata that doesn't respond to other treatments.

Tofacitinib works well for treating alopecia areata, especially when combined with corticosteroids, but is less effective if the disease has lasted over 2 years.

Tofacitinib is effective and safe for treating severe alopecia areata.

The new delivery system improved raloxifene's skin absorption and effectiveness against cancer cells.

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

Tofacitinib significantly improved hair loss and lesions in a patient with overlapping autoimmune disorders.

Avoiding friction and using topical treatments can significantly improve rough skin caused by repeated rubbing.

Tofacitinib, a hair regrowth treatment, may worsen acne.

Arabidopsis Formin 2 stabilizes actin filaments to aid cell-to-cell trafficking.